Max Robotics — Global Service Robot Directory + US Certification

About

Gerit Theil is a leading surgical researcher whose work is reshaping the landscape of kidney transplantation and oncology. Specializing in the comparative effectiveness of robotic-assisted versus open surgical techniques, Theil’s research directly addresses critical questions in postoperative recovery and patient safety. Their most-cited study, a prospective comparative analysis of systemic inflammatory syndrome following robot-assisted versus open kidney transplantation (17 citations), provides pivotal evidence on the benefits of minimally invasive approaches. Theil’s landmark contribution is the OpeRa trial, a randomized, controlled, open-label, multicenter study (12 citations) that rigorously evaluates whether robotic-assisted partial nephrectomy reduces 30-day complications in patients with intermediate-to-high-complexity kidney tumors—a definitive step toward evidence-based surgical decision-making. Additionally, Theil has engaged in essential clinical debate, as seen in their work "Robotic Donor Nephrectomy: Against" (8 citations), demonstrating a balanced, critical perspective on emerging technologies. Through high-impact clinical trials and thoughtful discourse, Gerit Theil is advancing the precision and safety of urologic and transplant surgery, offering surgeons and patients clearer guidance in an era of rapid technological change.